Active Ingredient(s):Lesinurad FDA Approved: * December 22, 2015 Pharm Company: *ARDEA BIOSCIENCES INC Category:Gout
Lesinurad (brand name Zurampic) is a urate transporter inhibitor for treating high blood uric acid levels associated with gout. It is only recommended together with either allopurinol or febuxostat when these medications are not sufficient.
It received FDA approval on 22 December 2015. The European Commission granted a marketing authorisation valid throughout the European Union on 18 February 2016. In February 2019, i...
* May have multiple approval dates, manufacturers, or labelers.